Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine in DKA with Renal Impairment
NCT05219942Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2020
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of insulin glargine in diabetic ketoacidosis (DKA) (2 arms), sponsored by Ain Shams University. Primary endpoints: Mean time to reversal of diabetic ketoacidosis at 48 hours and Total crystalline insulin consumption at 48 hours. Status: unknown.
02
Drugs
insulin glargine
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on NCT05219942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05219942.